The use of natural history (NH) studies early in clinical research can help facilitate development programs for orphan drugs.
Gajendra Chanchu
Advertisement
Articles by Gajendra Chanchu
The use of Natural History studies in order to examine a rare disease that will help facilitate drug development programs.
Advertisement
Latest Updated Articles
Researchers Conduct NH Studies for Rare Diseases and Drug DevelopmentPublished: October 16th 2017 | Updated:
- The Impetus for Natural History Studies in Rare Disease R&D
Published: April 1st 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Accelerating Site Payments with Agentic AI: See it in Action
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
